Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
Charles Okyere Boadu, Medical Laboratory Science Student at the University for Development Studies, shared on LinkedIn:
”Donating blood may protect more than patients.
It could help lower the risk of stroke and organ damage in some donors.
We all know that donating blood saves lives for patients battling cancer, undergoing surgery, surviving trauma, or managing chronic illnesses.
But beyond saving others, blood donation can sometimes help save your own life too.
Many people rarely go for routine medical check ups unless they feel sick.
Yet every time you donate blood, you go through a mandatory screening process including a haemoglobin test.
This simple test works like a mini health check and can reveal important clues about your internal health.
For example, some people unknowingly live with Polycythemia Vera, a rare condition where the body produces too many red blood cells.
Most people with this condition has no early symptoms, so it can remain hidden for a long time.
During donor screening, an unusually high haemoglobin level can become an early warning sign.
The laboratory scientist can then prompt the donor to visit the hospital for further checks, monitoring, education, and treatment.
In people diagnosed with Polycythemia Vera, therapeutic venesection is often done to reduce the thickness of the blood and lower the risk of complications.
If this condition is not detected early, the blood can become too thick and lead to life threatening complications such as stroke, heart attack, and other cardiovascular problems.
Imagine walking in to donate blood to save a stranger and discovering a condition that was silently threatening your own future.
The lesson is simple. When you step forward to save a life through blood donation, you may also uncover hidden health conditions that help protect your own life.
Donate blood. Save lives and possibly your own too.”

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026